Targeted biopsy of the prostate: improvement in detection of high-grade cancer, or the Will Rogers phenomenon?

[1]  A. Tewari,et al.  MRI-Targeted Biopsy for Prostate-Cancer Diagnosis. , 2018, The New England journal of medicine.

[2]  J. Brooks,et al.  Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts , 2018, Cancer.

[3]  James L Mohler,et al.  NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  D. Margolis,et al.  MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis , 2018, The New England journal of medicine.

[5]  J. Sterne,et al.  Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial , 2018, JAMA.

[6]  Ian A. Donaldson,et al.  Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach , 2017, Prostate Cancer and Prostatic Diseases.

[7]  M. Parmar,et al.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study , 2017, The Lancet.

[8]  D. Kuban,et al.  Current clinical presentation and treatment of localized prostate cancer in the United States. , 2014, The Journal of urology.

[9]  J. Babb,et al.  Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI. , 2013, AJR. American journal of roentgenology.

[10]  T. H. van der Kwast,et al.  Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. , 2013, Journal of the National Cancer Institute.

[11]  Raj Persad,et al.  Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? , 2013, Journal of magnetic resonance imaging : JMRI.

[12]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[13]  A. Haese*,et al.  Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade , 2011, BJU international.

[14]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[15]  H. Hricak,et al.  Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. , 2009, Radiology.

[16]  James A Hanley,et al.  Prostate cancer and the Will Rogers phenomenon. , 2005, Journal of the National Cancer Institute.

[17]  K. Grigor,et al.  Trends in reporting Gleason score 1991 to 2001: changes in the pathologist's practice. , 2005, European urology.

[18]  T. Miki,et al.  [Natural history of prostate cancer]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[19]  Michael Cookson.  Prostate cancer: screening and early detection. , 2001, Cancer control : journal of the Moffitt Cancer Center.

[20]  C. King,et al.  Patterns of prostate cancer biopsy grading: Trends and clinical implications , 2000, International journal of cancer.

[21]  J. Epstein,et al.  Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made. , 2000, The American journal of surgical pathology.

[22]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[23]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[24]  D. Gleason,et al.  PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING , 2017, The Journal of urology.

[25]  김광현,et al.  Extended vs standard lymph node dissection in robot‐assisted radical prostatectomy for intermediate‐ or high‐risk prostate cancer: a propensity‐score‐matching analysis , 2013, BJU international.

[26]  M. Terris,et al.  Changing nature of high risk patients undergoing radical prostatectomy. , 2007, The Journal of urology.

[27]  G. Chodak.  Prostate cancer: epidemiology, screening, and biomarkers. , 2006, Reviews in urology.

[28]  P. Walsh,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 2000, The Journal of urology.